photo of Prof David Burgner

Prof David Burgner

Prof David Burgner

Details

Role Group Leader / Principal Research Fellow
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.

Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.

Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.

Top Publications

  • Todd, IMF, Pedersen, LH, Miller, JE, Burgner, DP, Magnus, MC. Joint Effects of Prenatal Antibiotics, Mode of Birth and Breastfeeding Duration on Childhood Infections: The Norwegian MoBa Cohort Study.. Paediatr Perinat Epidemiol 2026
    view publication
  • Tiplady, CH, Mynard, JP, Vandeleur, M, Ainkaran, G, Li, SX, Climie, R, Burgner, DP, Dwyer, T, Quinlan, C, Longmore, DK. Lifestyle Interventions Addressing Blood Pressure in Children: A Systematic Review.. JAMA Pediatr 180(2) : 202 -211 2026
    view publication
  • Todd, IMF, Burgner, DP, Magnus, MC, Pedersen, LH, Miller, JE. Prenatal and intrapartum antibiotic exposure and childhood infections: considerations and complexities.. Lancet Reg Health Am 54: 101368 2026
    view publication
  • Holland, L, Drummond, K, Thomson, S, Sominsky, L, Marx, W, Love, C, Dawson, SL, Harrison, LC, Saffery, R, Symeonides, C, et al. Prenatal and birth factors associated with child autism diagnosis: a birth cohort perspective.. Pediatr Res 2026
    view publication
  • Burgner, D, Levin, M. Infectious Diseases: Predisposition. 2026
    view publication

Career information